1. Immunology/Inflammation Metabolic Enzyme/Protease Autophagy
  2. NOD-like Receptor (NLR) Farnesyl Transferase Autophagy
  3. Arglabin

Arglabin  (Synonyms: (+)-Arglabin)

Cat. No.: HY-16059 Purity: 99.87%
SDS COA Handling Instructions

Arglabin ((+)-Arglabin), a natural product isolated from Artemisia glabella, is a NLRP3 inflammasome inhibitor. Arglabin shows anti-inflammatory and antitumor activities. The antitumor activity of Arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene.

For research use only. We do not sell to patients.

Arglabin Chemical Structure

Arglabin Chemical Structure

CAS No. : 84692-91-1

Size Price Stock Quantity
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 396 In-stock
Solution
10 mM * 1 mL in DMSO USD 396 In-stock
Solid
1 mg USD 146 In-stock
5 mg USD 308 In-stock
10 mg USD 495 In-stock
25 mg USD 660 In-stock
50 mg USD 880 In-stock
100 mg USD 1320 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All NOD-like Receptor (NLR) Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Arglabin ((+)-Arglabin), a natural product isolated from Artemisia glabella, is a NLRP3 inflammasome inhibitor. Arglabin shows anti-inflammatory and antitumor activities[1]. The antitumor activity of Arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene[2].

IC50 & Target

NLRP3

 

Cellular Effect
Cell Line Type Value Description References
518A2 IC50
6.72 μM
Compound: 203
Cytotoxicity against human 518A2 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
Cytotoxicity against human 518A2 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
[PMID: 27996267]
A2780 IC50
12.55 μM
Compound: 11m
Cytotoxicity against human A2780 cells assessed as inhibition of cell growth incubated for 96 hrs by SRB assay
Cytotoxicity against human A2780 cells assessed as inhibition of cell growth incubated for 96 hrs by SRB assay
[PMID: 32526552]
A-431 IC50
4.48 μM
Compound: 203
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
Cytotoxicity against human A431 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
[PMID: 27996267]
A549 IC50
2.21 μM
Compound: 203
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
Cytotoxicity against human A549 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
[PMID: 27996267]
HT-29 IC50
7 μM
Compound: 203
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
Cytotoxicity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
[PMID: 27996267]
MCF7 IC50
2.33 μM
Compound: 203
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
Cytotoxicity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by SRB asssay
[PMID: 27996267]
In Vitro

The antitumor activity of arglabin proceeds through its inhibition of farnesyl transferase which leads to the activation of RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30% of all human tumors. It actually inhibits the incorporation of farnesyl pyrophosphate into human H-ras proteins by the enzyme farnesyl transferase (FTase)[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

Arglabin reduces inflammation and plasma lipids, increases autophagy, and orients tissue macrophages into an anti-inflammatory phenotype in ApoE2.Ki mice fed a high-fat diet[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

246.31

Formula

C15H18O3

CAS No.
Appearance

Solid

Color

White to light yellow

SMILES

C[C@]1(CC[C@](C2=C)([H])[C@@](OC2=O)([H])[C@@]3([H])C(C)=CC4)[C@]34O1

Structure Classification
Initial Source
Shipping

Room temperature in continental US; may vary elsewhere.

Storage
Powder -20°C 3 years
In solvent -80°C 6 months
-20°C 1 month
Solvent & Solubility
In Vitro: 

DMSO : ≥ 100 mg/mL (406.00 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

*"≥" means soluble, but saturation unknown.

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 4.0600 mL 20.3000 mL 40.5999 mL
5 mM 0.8120 mL 4.0600 mL 8.1200 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start)

C1

×
Volume (start)

V1

=
Concentration (final)

C2

×
Volume (final)

V2

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (10.15 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (10.15 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation

Purity: 99.87%

References

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 4.0600 mL 20.3000 mL 40.5999 mL 101.4998 mL
5 mM 0.8120 mL 4.0600 mL 8.1200 mL 20.3000 mL
10 mM 0.4060 mL 2.0300 mL 4.0600 mL 10.1500 mL
15 mM 0.2707 mL 1.3533 mL 2.7067 mL 6.7667 mL
20 mM 0.2030 mL 1.0150 mL 2.0300 mL 5.0750 mL
25 mM 0.1624 mL 0.8120 mL 1.6240 mL 4.0600 mL
30 mM 0.1353 mL 0.6767 mL 1.3533 mL 3.3833 mL
40 mM 0.1015 mL 0.5075 mL 1.0150 mL 2.5375 mL
50 mM 0.0812 mL 0.4060 mL 0.8120 mL 2.0300 mL
60 mM 0.0677 mL 0.3383 mL 0.6767 mL 1.6917 mL
80 mM 0.0507 mL 0.2537 mL 0.5075 mL 1.2687 mL
100 mM 0.0406 mL 0.2030 mL 0.4060 mL 1.0150 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Arglabin
Cat. No.:
HY-16059
Quantity:
MCE Japan Authorized Agent: